期刊文献+

PSGL-1在Apc^(Min/+)小鼠肠道肿瘤发生中的作用

The role of PSGL-1 in the growth of intestinal tumor in Apc^(Min/+) mice
下载PDF
导出
摘要 目的研究P-选凝素糖蛋白配体1(P-selectin glycoprotein ligand 1,PSGL-1)在ApcMin/+小鼠肠道肿瘤中的作用。方法PSGL-1基因缺失的基因工程小鼠和肠道肿瘤模型ApcMin/+小鼠杂交后,统计ApcMin/+小鼠与(ApcMin/+;PSGL-1-/-)杂交小鼠小肠及大肠肿瘤的数目和总负荷,观测其肠道肿瘤的发生变化。结果相比ApcMin/+小鼠,(ApcMin/+;PSGL-1-/-)杂交小鼠在18周龄时肠道肿瘤数目与总负荷有明显增加。结论 PSGL-1的缺失促进了ApcMin/+小鼠肠道肿瘤的发生,PSGL-1在人类肠道肿瘤中可能发挥着抑制肿瘤形成的作用。 Purpose To investigate the role of P-selectin glycoprotein ligand 1 ( PSGL-1 ) in ApcMin/+ mice intestinal tumors. Methods ApeMiKe+ was crossed with PSGL-l-deficient mice and the tumor susceptibility in intestine was compared. The small intestine and co- lon tumor number and the total tumor volume of ApcMin/+ mice and ApcMin/+ , PSGL-1 -/- mice were analyzed and the changes in intestinal tumor were observed. Results PSGL-1 deficiency in ApeMin/+ mice resulted in significant increase of tumor numbers and tumor vol- umes in the small intestine and total intestine at 18 weeks. Conclusion These findings have provided the genetic evidence for a tumor suppression role of PSGL-1 in the intestine of mice. Importantly, these studies also suggest that PSGL-1 may be a tumor suppressor for human intestinal tumors.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2012年第5期495-498,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 国家自然科学基金(30900764 21005022) 国家科技部"973"项目(2010CB529702)
关键词 肠道肿瘤 PSGL-1 ApcMin/+小鼠 intestinal neoplasms PSGL-1 ApcMin/+ mice
  • 相关文献

参考文献5

  • 1Kettunen H L,Kettunen A S,Rautonen N E.Intestinal immune responses in wild-type and ApcMin/ + mouse,a model for colon cancer[J].Cancer Res,2003,63(16):5136-42.
  • 2叶志金,郑力,亓翠玲,张敏,唐富天,王尽淘,耿建国,王丽京.APC^(Min/+)结直肠癌癌前病变小鼠模型的生物学特性[J].临床与实验病理学杂志,2011,27(4):393-395. 被引量:9
  • 3Raes G,Ghassabeh G H,Brys L,et al.The metastatic T-cell hybridoma antigen/P-selectin glycoprotein ligand 1 is required for hematogenous metastasis of lymphomas[J].Int J Cancer,2007,121(12):2646-52.
  • 4盛弘强,陈俭,来茂德.Min基因突变小鼠模型在肠道肿瘤研究中的应用[J].遗传,2008,30(3):277-282. 被引量:8
  • 5Dove W F,Clipson L,Gould K A,et al.Intestinal neoplasia in the ApcMin mouse:independence from the microbial and natural killer (beige locus) status[J].Cancer Res,1997,57(5):812-4.

二级参考文献53

  • 1张丽丽,吴建新.DNA甲基化——肿瘤产生的一种表观遗传学机制[J].遗传,2006,28(7):880-885. 被引量:54
  • 2Nathke I S.The adenomatous polyposis coli protein:the Achilles heel of the gut epithelium[J].Annu Rev Cell Dev Biol,2004,20:337-66.
  • 3Su L K,Kinzler K W,Vogelstein B,et al.Multiple intestinal neo-plasia caused by a mutation in the murine homolog of the APC gene[J].Science,1992,256(5060):1114.
  • 4Taketo M M,Edelmann W.Mouse models of colon cancer[J].Gastroenterology,2009,136(3):780-98.
  • 5Yamada T,Mori Y,Hayashi R,et al.Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice[J].Cancer Res,2003,63(5):895-901.
  • 6Roberts R B,Min L,Washington M K,et al.Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis[J].Proc Natl Acad Sci USA,2002,99(3):1521-6.
  • 7Mcalpine C A,Barak Y,Matise I,Cormier R T.Intestinal-specific PPARgamma deficiency enhances tumorigenesis in APCMin/+ mice[J].Int J Cancer,2006,119(10):2339-46.
  • 8Korsisaari N,Kasman I M,Forrest W F,et al.Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc+/min mice[J].Proc Natl Acad Sci USA,2007,104(25):10625-30.
  • 9Urbanska A M,Bhathena J,Martoni C,et al.Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the attenuation of tumorigenesis in Apc(Min/+)mice[J].Dig Dis Sci,2009,54(2):264-73.
  • 10Baltgalvis K A,Berger F G,Pena M M,et al.The interaction of a high-fat diet and regular moderate intensity exercise on intestinal polyp development in Apc Min/+ mice[J].Cancer Prev Res (Phila),2009,2(7):641-9.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部